Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-13

Clinical Trial Update: Oral Thiamine for the Treatment of Painful Diabetic Peripheral Neuropathy [NA]

View source ↗

Summary

A clinical trial evaluating oral thiamine for painful diabetic peripheral neuropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thiamine (thiamine)

Snippet

Sponsor: Loma Linda University | Conditions: Peripheral Neuropathy, Diabetes Mellitus | NA | Status: WITHDRAWN